Sai Parenterals share price
NSE: SAIPARENTBSE: 544742Pharmaceuticals & BiotechnologySmall Cap
Last close ₹461.70up ₹10.20 (2.26%)BSE ₹462.55
Share price at the NSE close on 23 Oct 2026. Previous close ₹451.50.
Range of traded prices from listing on 2 Apr 2026 to 23 Oct 2026
₹400.00Low, 2 Apr 2026₹706.00High, 2 Jul 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹2,040 Cr1,118th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- No full year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 23 May 2026
- 4.2
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonesince listing in Apr 2026
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 23 May 2026
- 0.65
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 3,20,04060.5% delivered
Results
Consolidated; ₹ crore, the charts by years to March, the table by quarter.Quarterly results
Quarter to Jun 2026, against the quarter beforeFiled 11 Aug
- RevenueRevenue. The pill is the change in revenue against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹179 Crdown 9.73%
- Net profitNet profit. The pill is the change in net profit against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹7.92 Crdown 39.79%
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax.
- 4.4%
Revenue by year
Net profit by year, a loss in red
| ₹ crore | Dec 2025Filed 23 May | Mar 2026Filed 23 May | Jun 2026Filed 11 Aug |
|---|---|---|---|
| Revenue | 96 | 198 | 179 |
| Net profit | −7 | 13 | 8 |
| Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. | −6.9% | 6.6% | 4.4% |
Consolidated. The 3 quarters from Dec 2025, the first on record. The latest is shaded. Net profit is the whole group's, the other owners of its subsidiaries included; P/E and ROE use the company's own share.
Business segments
In the year to Mar 2026 the company reports one business segment, pharmaceutical, which carries all its revenue.
Mutual funds holding it
5 funds disclosed a holding for Sep 2026. What they did in Sep 2026, against each fund's month before.
- Bought for the first timeBought for the first time. Funds that held it at the month's end and had not held it in any month on record before.
- 2
- AddedAdded. Funds that held more shares than at the end of the month before.
- 2
- Held unchangedHeld unchanged. Funds that held the same number of shares as at the end of the month before.
- 1
| Fund | |||
|---|---|---|---|
 Bandhan Healthcare FundBandhan Mutual Fund | 70,830 | 1.15% | ₹3.75 Cr |
| Bandhan Midcap FundBandhan Mutual Fund | 52,115 | 0.11% | ₹2.76 Cr |
| Bandhan Large & Mid Cap FundBandhan Mutual Fund | 10,862 | – | ₹0.57 Cr |
 Motilal Oswal BSE Healthcare ETFMotilal Oswal Mutual Fund | 332 | 0.04% | ₹0.02 Cr |
| Bandhan BSE Healthcare Index FundBandhan Mutual Fund | 157 | 0.04% | ₹83,000 |
Portfolios disclosed for Sep 2026. Weight is the holding as a share of the fund's assets.
Peers and competitors
Pharmaceuticals, 216 listed companies, priced on 23 Oct 2026. The table lists the 8 companies closest to Sai Parenterals in market cap.
Sai Parenterals is not on the chart: it has no P/E or return on equity today
| Company | |||||||||
|---|---|---|---|---|---|---|---|---|---|
 Fredun PharmaceuticalsFREDUN | 2,313 | – | 8.3 | 23.6 | – | – | – | 18.8% | 0.02% |
 Dishman Carbogen AmcisDCAL | 2,137 | 132.2 | 0.3 | 8.1 | +0.2% | −84.5% | 0.3% | 1.4% | 0.00% |
 Beta DrugsBETA | 2,107 | 39.0 | 4.8 | 22.2 | – | – | 16.4% | 14.2% | 0.00% |
 Indoco RemediesINDOCO | 2,091 | 371.3 | 2.2 | 18.7 | +12.1% | – | 0.6% | 1.7% | 0.09% |
 Syncom Formulations (India)SYNCOMF | 1,992 | 23.3 | 4.8 | 22.6 | +0.4% | +48.6% | 22.6% | 19.5% | 0.47% |
 Sakar HealthcareSAKAR | 1,980 | 46.2 | 5.7 | 22.4 | +48.0% | +119.8% | 13.2% | 16.6% | 0.00% |
 Panacea BiotecPANACEABIO | 1,908 | – | 2.3 | 852.5 | +10.3% | −162.0% | −0.9% | −3.6% | 0.00% |
 Venus RemediesVENUSREM | 1,877 | 16.2 | 2.8 | 11.1 | +19.9% | +116.3% | 19.0% | 21.1% | 0.71% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Latest announcements
Routine notices left out.Share news and announcements
Oct 2026
1 Oct · Analysts
Sep 2026
30 Sep · Management
30 Sep · Board meeting
10 Sep · Meeting
Recent sessions
The last 10 trading days to 23 Oct 2026, as traded on NSE.
| Date | Open | High | Low | Close | Average price | Volume | Delivery |
|---|---|---|---|---|---|---|---|
| 23 Oct 2026 | 460.55 | 472.45 | 441.35 | 461.70 | 454.25 | 3,20,040 | 60.5% |
| 22 Oct 2026 | 464.00 | 465.25 | 448.15 | 451.50 | 455.37 | 2,30,332 | 55.7% |
| 21 Oct 2026 | 478.70 | 488.15 | 462.10 | 467.60 | 470.80 | 2,00,138 | 58.1% |
| 19 Oct 2026 | 483.20 | 490.75 | 482.10 | 483.00 | 485.02 | 65,785 | 63.3% |
| 16 Oct 2026 | 483.90 | 492.80 | 480.90 | 487.30 | 487.77 | 53,936 | 55.1% |
| 15 Oct 2026 | 500.00 | 500.00 | 482.00 | 483.90 | 487.63 | 92,729 | 59.5% |
| 14 Oct 2026 | 497.25 | 504.00 | 491.65 | 495.55 | 498.16 | 56,607 | 46.5% |
| 13 Oct 2026 | 504.00 | 504.00 | 492.00 | 498.30 | 496.95 | 62,283 | 53.8% |
| 12 Oct 2026 | 493.20 | 515.70 | 488.10 | 504.00 | 503.64 | 1,78,937 | 55.3% |
| 9 Oct 2026 | 500.00 | 508.00 | 485.00 | 493.90 | 498.41 | 1,45,255 | 50.2% |
Prices in ₹ per share as traded, not adjusted.
Company details
- Legal name
- Sai Parenterals Limited
- NSE symbol
- SAIPARENT
- BSE code
- 544742
- ISIN
- INE0H9F01037
- Industry
- Pharmaceuticals & Biotechnology
- Listed
- Apr 2026
- Face value
- ₹5